Your browser doesn't support javascript.
loading
LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.
Corrales, Leticia; Hipp, Susanne; Martin, Katharina; Sabarth, Nicolas; Tirapu, Iñigo; Fuchs, Klaus; Thaler, Barbara; Walterskirchen, Christian; Bauer, Kathrin; Fabits, Markus; Bergmann, Michael; Binder, Carina; Chetta, Paolo Ml; Vogt, Anne B; Adam, Paul J.
Afiliación
  • Corrales L; Boehringer Ingelheim Regional Center Vienna (RCV), GmbH & Co KG., Cancer Immunology & Immune Modulation, Vienna, Austria.
  • Hipp S; Boehringer Ingelheim Regional Center Vienna (RCV), GmbH & Co KG., Cancer Immunology & Immune Modulation, Vienna, Austria.
  • Martin K; Boehringer Ingelheim Pharmaceuticals, Inc., Translational Medicine and Clinical Pharmacology, Ridgefield, CT, United States.
  • Sabarth N; Boehringer Ingelheim Regional Center Vienna (RCV), GmbH & Co KG., Cancer Immunology & Immune Modulation, Vienna, Austria.
  • Tirapu I; Boehringer Ingelheim Regional Center Vienna (RCV) GmbH & Co KG., Biotherapeutics Discovery, Vienna, Austria.
  • Fuchs K; Boehringer Ingelheim Regional Center Vienna (RCV), GmbH & Co KG., Cancer Immunology & Immune Modulation, Vienna, Austria.
  • Thaler B; Boehringer Ingelheim Pharma, GmbH & Co KG, Biotherapeutics Discovery, Biberach, Germany.
  • Walterskirchen C; Boehringer Ingelheim Regional Center Vienna (RCV), GmbH & Co KG., Cancer Immunology & Immune Modulation, Vienna, Austria.
  • Bauer K; Boehringer Ingelheim Regional Center Vienna (RCV), GmbH & Co KG., Cancer Immunology & Immune Modulation, Vienna, Austria.
  • Fabits M; Boehringer Ingelheim Regional Center Vienna (RCV), GmbH & Co KG., Cancer Immunology & Immune Modulation, Vienna, Austria.
  • Bergmann M; Division of Visceral Surgery, Department of General Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Binder C; Division of Visceral Surgery, Department of General Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Chetta PM; Department of Pathology, Medical University of Vienna, Vienna, Austria.
  • Vogt AB; Boehringer Ingelheim RCV, GmbH & Co KG., Oncology Translational Science, Vienna, Austria.
  • Adam PJ; Boehringer Ingelheim Regional Center Vienna (RCV), GmbH & Co KG., Cancer Immunology & Immune Modulation, Vienna, Austria.
Front Immunol ; 13: 1008764, 2022.
Article en En | MEDLINE | ID: mdl-36159851
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Factor de Necrosis Tumoral alfa Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Austria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Factor de Necrosis Tumoral alfa Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Austria